A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms

Annals of Neurology

Volumn 80, Issue 4, 2016, Pages 581-592

  Baykara, Ebru ^a   Gesierich, Benno ^a   Adam, Ruth ^a   Tuladhar, Anil Man ^b   Biesbroek, J Matthijs ^c   Koek, Huiberdina L ^c   Ropele, Stefan ^d   Jouvent, Eric ^e,f,g   Chabriat, Hugues ^e,f,g   Ertl Wagner, Birgit ^a   Ewers, Michael ^a   Schmidt, Reinhold ^d   de Leeuw, Frank Erik ^b   Biessels, Geert Jan ^c   Dichgans, Martin ^a,h,i   Duering, Marco ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f DHU NeuroVasc Paris Sorbonne   (France)

^g HÔPITAL LARIBOISIÈRE   (France)

^h Munich Cluster for Systems Neurology ^*  (Germany)

ⁱ GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN HEMORRHAGE; BRAIN SIZE; BRAIN VENTRICLE; CADASIL; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HISTOGRAM; HUMAN; IMAGE PROCESSING; IMAGING SOFTWARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; REPRODUCIBILITY; WHITE MATTER; COGNITIVE DYSFUNCTION; COMPLICATION; DIAGNOSTIC IMAGING; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; STANDARDS; VALIDATION STUDY; VERY ELDERLY; YOUNG ADULT;

BIOLOGICAL MARKER;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOMARKERS; CEREBRAL SMALL VESSEL DISEASES; COGNITIVE DYSFUNCTION; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; WHITE MATTER; YOUNG ADULT;

EID: 84983652653     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24758     Document Type: Article

References (48)

1. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010;9:689–701.
2. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822–838.
3. Wardlaw JM, Valdés Hernández MC, Muñoz-Maniega S. What are white matter hyperintensities made of? Relevance to vascular cognitive impairment. J Am Heart Assoc 2015;4:001140.
4. Nitkunan A, Barrick TR, Charlton RA, et al. Multimodal MRI in cerebral small vessel disease: its relationship with cognition and sensitivity to change over time. Stroke 2008;39:1999–2005.
5. Patel B, Markus HS. Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker. Int J Stroke 2011;6:47–59.
6. Duering M, Zieren N, Herve D, et al. Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL. Brain 2011;134(pt 8):2366–2375.
7. Viswanathan A, Godin O, Jouvent E, et al. Impact of MRI markers in subcortical vascular dementia: a multi-modal analysis in CADASIL. Neurobiol Aging 2010;31:1629–1636.
8. Frisoni GB, Fox NC, Jack CR, et al. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 2010;6:67–77.
9. De Guio F, Reyes S, Duering M, et al. Decreased T1 contrast between gray matter and normal-appearing white matter in CADASIL. AJNR Am J Neuroradiol 2014;35:72–76.
10. O'Sullivan M, Jouvent E, Saemann PG, et al. Measurement of brain atrophy in subcortical vascular disease: a comparison of different approaches and the impact of ischaemic lesions. Neuroimage 2008;43:312–320.
11. Smith EE, Schneider JA, Wardlaw JM, Greenberg SM. Cerebral microinfarcts: the invisible lesions. Lancet Neurol 2012;11:272–282.
12. Charidimou A, Werring DJ. Cerebral microbleeds and cognition in cerebrovascular disease: an update. J Neurol Sci 2012;322:50–55.
13. Nucifora PGP, Verma R, Lee S-K, Melhem ER. Diffusion-tensor MR imaging and tractography: exploring brain microstructure and connectivity. Radiology 2007;245:367–384.
14. Van Norden AGW, De Laat KF, Van Dijk EJ, et al. Diffusion tensor imaging and cognition in cerebral small vessel disease: the RUN DMC study. Biochim Biophys Acta 2012;1822:401–417.
15. Tuladhar AM, van Norden AGW, de Laat KF, et al. White matter integrity in small vessel disease is related to cognition. Neuroimage Clin 2015;7:518–524.
16. Tofts PS, Davies GR, Dehmeshki J. Histograms: measuring subtle diffuse disease. In: Tofts P, ed. Quantitative MRI of the brain. Chichester, UK: John Wiley & Sons, 2003:581–610.
17. Duering M, Csanadi E, Gesierich B, et al. Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease. Brain 2013;136(pt 9):2717–2726.
18. Tombaugh TN. Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol 2004;19:203–214.
19. van Norden AG, de Laat KF, Gons RA, et al. Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol. BMC Neurol 2011;11:29.
20. van der Elst W, van Boxtel MPJM, van Breukelen GJP, Jolles J. The Concept Shifting Test: adult normative data. Psychol Assess 2006;18:424–432.
21. van der Elst W, van Boxtel MPJ, van Breukelen GJP, Jolles J. Assessment of information processing in working memory in applied settings: the paper and pencil memory scanning test. Psychol Med 2007;37:1335–1344.
22. Aalten P, Ramakers IH, Biessels GJ, et al. The Dutch Parelsnoer Institute—Neurodegenerative diseases; methods, design and baseline results. BMC Neurol 2014;14:1–8.
23. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183–194.
24. Ghadery C, Pirpamer L, Hofer E, et al. R2* mapping for brain iron: associations with cognition in normal aging. Neurobiol Aging 2015;36:925–932.
25. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1):S208–S219.
26. Zwiers MP. Patching cardiac and head motion artefacts in diffusion-weighted images. Neuroimage 2010;53:565–575.
27. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487–1505.
28. R Core Team. A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2014.
29. Decarli C, Maillard P, Fletcher E. Four Tissue Segmentation in ADNI II. 2013. Available at: https://www.alz.washington.edu/WEB/adni_proto.pdf. Accessed Feb 5, 2016
30. Otsu N. A threshold selection method from gray level histogram. IEEE Trans Syst Man Cybern 1979;9:62–66.
31. Fox J, Weisberg S. An {R} Companion to Applied Regression, Second Edition. Thousand Oaks CA: Sage, 2011. Available at: http://socserv.socsci.mcmaster.ca/jfox/Books/Companion. Accessed Feb 5, 2016.
32. Lindeman RH, Merenda PF, Gold RZ. Introduction to bivariate and multivariate analysis. Glenview, IL: Scott Foresman and Company, 1980.
33. Grömping U. Relative importance for linear regression in R: the package relaimpo. J Stat Softw 2006;17:139–147.
34. Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175–191.
35. Maillard P, Fletcher E, Harvey D, et al. White matter hyperintensity penumbra. Stroke 2011;42:1917–1922.
36. De Groot M, Verhaaren BFJ, De Boer R, et al. Changes in normal-appearing white matter precede development of white matter lesions. Stroke 2013;44:1037–1042.
37. Lawrence AJ, Patel B, Morris RG, et al. Mechanisms of cognitive impairment in cerebral small vessel disease: multimodal MRI results from the St George's cognition and neuroimaging in stroke (SCANS) study. PLoS One 2013;8:e61014.
38. Jokinen H, Schmidt R, Ropele S, et al. Diffusion changes predict cognitive and functional outcome: the LADIS study. Ann Neurol 2013;73:576–583.
39. van Norden AGW, van Uden IWM, de Laat KF, et al. Cognitive function in small vessel disease: the additional value of diffusion tensor imaging to conventional magnetic resonance imaging: the RUN DMC study. J Alzheimers Dis 2012;32:667–676.
40. Holtmannspotter M, Peters N, Opherk C, et al. Diffusion magnetic resonance histograms as a surrogate marker and predictor of disease progression in CADASIL: a two-year follow-up study. Stroke 2005;36:2559–2565.
41. Molko N, Pappata S, Mangin JF, et al. Monitoring disease progression in CADASIL with diffusion magnetic resonance imaging: a study with whole brain histogram analysis. Stroke 2002;33:2902–2908.
42. Metzler-Baddeley C, O'Sullivan MJ, Bells S, et al. How and how not to correct for CSF-contamination in diffusion MRI. Neuroimage 2012;59:1394–1403.
43. Berlot R, Metzler-Baddeley C, Jones DK, O'Sullivan MJ. CSF contamination contributes to apparent microstructural alterations in mild cognitive impairment. Neuroimage 2014;92:27–35.
44. Grech-Sollars M, Hales PW, Miyazaki K, et al. Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain. NMR Biomed 2015;28:468–485.
45. Cercignani M, Bammer R, Sormani MP, et al. Inter-sequence and inter-imaging unit variability of diffusion tensor MR imaging histogram-derived metrics of the brain in healthy volunteers. Am J Neuroradiol 2003;24:638–643.
46. Gunda B, Porcher R, Duering M, et al. ADC histograms from routine DWI for longitudinal studies in cerebral small vessel disease: a field study in CADASIL. PLoS One 2014;9:e97173.
47. Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol 2015;11:157–165.
48. Benjamin P, Zeestraten E, Lambert C, et al. Progression of MRI markers in cerebral small vessel disease: sample size considerations for clinical trials. J Cereb Blood Flow Metab 2016;36:228–240.